seed
Stage
2007
Founded
1
Investors
About
aTyr Pharma is a clinical-stage biopharmaceutical company that develops novel therapeutics leveraging extracellular tRNA synthetase biology to treat fibrosis, inflammation, and rare pulmonary diseases such as pulmonary sarcoidosis and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Explore aTyr Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.